Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of Life
NCT07044778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1003
Last updated 2025-07-03
Summary
Overactive bladder (OAB) is defined as sudden, urgent desire to urinate (urgency) accompanied by frequency and nocturia, with or without urgent urinary incontinence in the absence of urinary tract infection (UTI). This condition can significantly decrease the quality of life of these patients, as it can humiliate their actions, affect their relationships with others, and it can also affect their productivity. Due to all these effects, several studies have linked the increase in overactive bladder symptoms with an increase in anxiety and depression rates. A recent cross-sectional study in the UK and Sweden, called EpiLUTS, included 10,000 participants. the investigators found a statistically significant increase in anxiety and depression rates among both men and women in both the UK and Sweden, with a slight increase in men than women On the other hand, there are several risk factors such as overweight, smoking, diabetes, and hypertension. In a previous cross-sectional study in Jordan, the investigators found a correlation between an increase in risk factors such as age group, history of trauma, stressful life, and medication, and overactive bladder symptoms among medical students.
Several studies have assessed the prevalence of overactive bladder among different population age groups, ethnicities, or genders with varying results. It was rated to be 11.8% in a multicenter cross-sectional study including several countries in Canada and Europe (Germany, Italy, Sweden, and the UK), while in the USA it was estimated to be 16%. All these studies were conducted on the general population; however, in China, it was about 6% among university students.
In the Arab world, several cross-sectional studies have also assessed the prevalence of overactive bladder, including students, and its effect on the quality of life. Hajjar 2022 assessed its prevalence among Lebanese female nulliparae university students. They showed that nocturia and frequency were the most common symptoms that bothered students. the investigators also found a statistical correlation between smoking, drinking coffee, or tea, and increased symptoms. Also, drinking soft drinks was associated with an increase in urinary leakage. Additionally, Abuorouq 2024 and Shawahna 2021 conducted Cross-sectional studies were conducted on medical students in Jordan and Palestine, respectively. They reported a prevalence of 44.5% and 54.1%, respectively. Shawahna 2021 reported a statistically significant correlation between gender or stressful life and a decrease in quality of life.
Rational In Egypt, the prevalence of overactive bladder is underestimated. A single previous multinational cross-sectional study across several Arab countries, including Egypt, was conducted. was conducted in Egypt, Algeria, Jordan, and Lebanon among women. the investigators reported a prevalence of 57.5% among Egyptian women.
Since this study, no study has been conducted to further assess its prevalence in different age or gender groups in Egypt. Taking into consideration the stressful life of medical students in Egypt, and several life risk factors they face, the investigators will conduct this cross-sectional study.
Conditions
- Overactive Bladder Syndrome
Interventions
- OTHER
-
Questionnaire
An online Questionnaire designed by Google Forms will be shared on social media for medical students in Egypt to fill
Sponsors & Collaborators
-
Zagazig University
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 27 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-05-15
- Primary Completion
- 2025-06-15
- Completion
- 2025-06-25
Countries
- Egypt
Study Locations
More Related Trials
-
Overactive Bladder Syndrome
NCT05151081 ·Status: COMPLETED
-
Overactive Bladder Education
NCT02505607 ·Status: TERMINATED ·Phase: NA
-
Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes
NCT07025642 ·Status: RECRUITING ·Phase: NA
-
Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
NCT02197533 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
NCT01868516 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of KUC-7483 in Patients With Overactive Bladder
NCT00742833 ·Status: COMPLETED ·Phase: PHASE2
-
AQUA: Anticholinergic Side Effects QUestionnAire
NCT04791111 ·Status: COMPLETED
-
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
NCT02386072 ·Status: COMPLETED
-
Behavioural Therapy With Checklist for Overactive Bladder
NCT03662893 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
NCT06024005 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute
NCT04635566 ·Status: COMPLETED ·Phase: NA
-
Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive Bladder
NCT04511273 ·Status: UNKNOWN
-
Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
NCT06408051 ·Status: COMPLETED
-
Management of OAB in Female Patients .
NCT06184334 ·Status: COMPLETED ·Phase: NA
-
OnabotulinumtoxinA Bladder Injection Study
NCT03523091 ·Status: TERMINATED ·Phase: PHASE4
-
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193 ·Status: ENROLLING_BY_INVITATION
-
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
NCT01210859 ·Status: WITHDRAWN
-
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder
NCT04917315 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin
NCT04023253 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
Oxybutynin and Omega-3 for OAB (Overactive Bladder)
NCT02070042 ·Status: TERMINATED ·Phase: NA
-
Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women
NCT03807024 ·Status: COMPLETED
-
Acupuncture Combined With Mirabegron in the Treatment of OAB
NCT06181019 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Predictors for Retreatement of OAB After DC Mirabegron
NCT04550702 ·Status: COMPLETED